Quest Diagnostics Financial Statements
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Quest Diagnostics revenue and earnings
In fiscal 2025, Quest Diagnostics generated $11.04 billion in revenue, up 11.8% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $992.0 million (+13.9% year over year), for a net margin of 9.0% versus a median of 9.6% in the prior 5 years. Gross margin was 33.2% (up from 32.9%) and operating margin 14.1%.
Diluted earnings per share came in at $8.75, up from $7.69. Over the last 5 fiscal years, DGX's revenue has grown at a 3.2% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Quest Diagnostics income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.04B | 9.87B | 9.25B | 9.88B | 10.79B | 9.44B | 7.73B | 7.53B | 7.40B | 7.21B |
| Revenue growth (YoY) | +11.78% | +6.70% | -6.38% | -8.39% | +14.32% | +22.15% | +2.59% | +1.74% | +2.61% | -3.72% |
| Cost of Revenue | 7.37B | 6.63B | 6.20B | 6.45B | 6.58B | 5.80B | 5.04B | 4.93B | 4.72B | 4.62B |
| Gross Profit | 3.67B | 3.24B | 3.05B | 3.43B | 4.21B | 3.63B | 2.69B | 2.60B | 2.68B | 2.90B |
| Operating Expenses | 2.11B | 1.90B | 1.79B | 2.00B | 1.83B | 1.66B | 1.46B | 1.50B | 1.52B | 1.62B |
| Selling, General & Admin | 1.97B | 1.77B | 1.64B | 1.87B | 1.73B | 1.55B | 1.46B | 1.42B | 1.44B | 1.38B |
| Operating Income | 1.56B | 1.35B | 1.26B | 1.43B | 2.38B | 1.97B | 1.23B | 1.10B | 1.17B | 1.28B |
| Interest Expense | 277.00M | 226.00M | 163.00M | 148.00M | 152.00M | 166.00M | 180.00M | 169.00M | 153.00M | 144.00M |
| Other Income (Expense) | -238.00M | -171.00M | -132.00M | -193.00M | 218.00M | -87.00M | -155.00M | -175.00M | -135.00M | -191.00M |
| Pretax Income | 1.32B | 1.18B | 1.13B | 1.24B | 2.60B | 1.88B | 1.08B | 926.00M | 1.03B | 1.09B |
| Income Tax | 314.00M | 273.00M | 248.00M | 264.00M | 597.00M | 460.00M | 247.00M | 182.00M | 241.00M | 429.00M |
| Net Income | 992.00M | 871.00M | 854.00M | 946.00M | 2.00B | 1.43B | 858.00M | 736.00M | 772.00M | 645.00M |
| Net Income growth (YoY) | +13.89% | +1.99% | -9.73% | -52.58% | +39.41% | +66.78% | +16.58% | -4.66% | +19.69% | -9.03% |
| EPS (Basic) | 8.87 | 7.78 | 7.59 | 8.10 | 15.85 | 10.62 | 6.36 | 5.39 | 5.63 | 4.58 |
| EPS (Diluted) | 8.75 | 7.69 | 7.49 | 7.97 | 15.55 | 10.47 | 6.28 | 5.29 | 5.50 | 4.51 |
| Shares Outstanding (Basic) | 111.00M | 111.00M | 112.00M | 116.00M | 125.00M | 134.00M | 134.00M | 136.00M | 137.00M | 140.00M |
| Shares Outstanding (Diluted) | 113.00M | 113.00M | 113.00M | 118.00M | 128.00M | 136.00M | 136.00M | 139.00M | 140.00M | 142.00M |
| EBITDA | 2.13B | 1.84B | 1.70B | 1.86B | 2.79B | 2.33B | 1.56B | 1.41B | 1.44B | 1.53B |
| Gross Margin | 33.21% | 32.86% | 33.00% | 34.74% | 39.02% | 38.50% | 34.80% | 34.59% | 36.25% | 40.19% |
| Operating Margin | 14.10% | 13.63% | 13.64% | 14.45% | 22.07% | 20.89% | 15.93% | 14.62% | 15.74% | 17.70% |
| Net Margin | 8.99% | 8.82% | 9.23% | 9.57% | 18.49% | 15.16% | 11.11% | 9.77% | 10.43% | 8.94% |
This table shows 10 annual periods of Quest Diagnostics's income statement, from FY 2025 back to FY 2016, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow DGX's reporting calendar. What is a income statement?